Diabetes drug cancer hope4th June 2009
Research published in the journal Nature has suggested that a common anti-diabetes drug may boost the potency of vaccines against cancer.
Tests on mice found metformin, used for type 2 diabetes, helps the body's T-cells work more effectively. The team from McGill University and the University of Pennsylvania used an experimental cancer vaccine and found that when administered in mice, the diabetes drug appeared to improve the strength of the inoculation. Cancer Research UK described the work as "a fascinating piece of research".
Share this page
There are no comments for this article, be the first to comment!
Post your comment
Only registered users can comment. Fill in your e-mail address for quick registration.
Title: Diabetes drug cancer hope
Author: Mark Nicholls
Article Id: 11635
Date Added: 4th Jun 2009